ArticleIndian journal of sexually transmitted diseases and AIDS
A retrospective study to assess the accuracy of syphilis rapid test by chemiluminescent microparticle immunoassay (CIA) in volunteer blood donors.
Article in Indian journal of sexually transmitted diseases and AIDS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Syphilis screening methods in blood banks have recently transitioned from manual nontreponemal tests to automated treponemal-specific enzyme immunoassays and chemiluminescence immunoassays (CIA). Although convenient and highly sensitive, this has led to increased false-positive rates leading to the wastage of blood resources. Aims and Objectives: This study aimed to evaluate the positive predictive value (PPV) of Patients and Methods: It was a retrospective observational study that collected data from July 2019 to May 2023 on blood bank donors referred to the sexually transmitted disease clinic, in view of testing reactive on the Abbott ARCHITECT Syphilis TP CMIA (relative light unit [RLU] >1). Clinical details, Venereal Disease Research Laboratory (VDRL) titers, and confirmatory TP hemagglutination (TPHA) test records were corroborated. Results: A total of 1791 patients were referred over 4 years as per blood bank records. Only 271 (15.13%) of these presented to the sexually transmitted infection clinic, indicating a high referral loss. Of patients with CIA titers available, 119/202 (58.9%) were diagnosed as confirmed syphilis based on VDRL and TPHA positivity, out of which majority (92.4%) were latent syphilis. PPV of TP-CIA rapid test at RLU >1 (manufacturer recommendation) was 64.3%, with an area under the receiver operating characteristic curve of 0.86. Setting the cutoff at RLU ≥2.5 improved sensitivity to 100% (patients with RLU <2.5 could be safely returned to the donor pool), while a cutoff of ≥24.63 achieved 100% specificity (confirmed syphilis). Conclusion: The manufacturer cutoff for syphilis CMIA rapid test (RLU >1) maintains high sensitivity but generates high false positives, causing nearly one-third of patients to be referred unnecessarily, as well as blood wastage. Reflexive confirmatory testing with a second treponemal assay can minimize the psychological impact on healthy donors and prevent unnecessary donor exclusion. Large-scale studies are required to establish population-based cutoffs for ensured blood safety without wastage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.